Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsProbiotics in inflammatory bowel diseases and associated conditionsSystematic review: the efficacy of herbal therapy in inflammatory bowel diseaseDietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitisUse of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.Potential role of nutraceutical compounds in inflammatory bowel diseaseResveratrol suppresses colitis and colon cancer associated with colitis.A survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologistsDistinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.Features of complementary and alternative medicine use by patients with coronary artery disease in Beijing: a cross-sectional study.Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicineSnapshot of an integrated psychosocial gastroenterology servicePublic awareness, patterns of use and attitudes toward natural health products in Kuwait: a cross-sectional survey.Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey.How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndromePatient defined dichotomous end points for remission and clinical improvement in ulcerative colitis.Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.Is chiropractic a CAM therapy or is it a separate profession?Inflammatory bowel disease: a Canadian burden of illness reviewGinkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosisComplementary and alternative medicines versus prescription drugs: perceptions of emergency department patients.American ginseng suppresses inflammation and DNA damage associated with mouse colitis.Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.Factors associated with the use of probiotics in patients with inflammatory bowel disease.Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.Use of complementary and alternative medicine by patients with inflammatory bowel disease.Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.An analysis of online messages about probiotics.Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided.Ginkgo biloba extract EGb 761-induced upregulation of LincRNA-p21 inhibits colorectal cancer metastasis by associating with EZH2.Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.
P2860
Q22242050-21A96297-49D0-4201-8605-05C1DB9146D8Q27002496-33CDAA60-A910-4972-AED0-910D2A18C7DAQ27004516-322DFA9D-D945-40D9-86CA-29AE246A78C3Q27021100-0B2DFB0E-819A-4962-8EA7-D2C38DE900F7Q33244259-592C5A77-5898-41A3-89E5-A324431BC1DBQ33572633-E4BD54EC-C6D8-4908-9FB1-7BA4D3B48543Q33785741-E8D1D1FE-A283-49F1-9327-376D692D04BFQ33810124-72E32247-4BC5-40C5-9984-E999B7CA118EQ34075201-06AD04B8-F7D5-4C46-9B02-D47D68ADA0DDQ34152778-53506768-0D53-49E2-BD03-E976D0361B31Q34454367-15211257-3B5C-4AC0-972C-B17A33CDC173Q35026510-A234C621-4FAD-44D3-B7EE-50E0342DEA02Q35064501-E36E0E84-491A-402E-A58B-A291CAB5FD17Q35069505-F902B678-957A-476C-ABE8-8D1D926400AAQ35124788-DAD2B4C9-6AFD-45D5-8CED-E3F0134B6E56Q35216610-7E62078D-C838-426A-ACBF-D46F3051E82DQ35457152-E55AD0AD-8E45-47F7-B361-29BB57A80992Q35597495-FCB11525-926C-4E82-A459-7F14D1C287EBQ35649251-F201B0A5-4FE2-4FB2-9E3F-E6537B2E9A89Q35728925-AE23D2E2-FED2-4DF9-9369-77BE3CF6E6ADQ36391797-9F850A59-6C48-466A-967B-9E872D9A4D43Q36857579-75444878-B078-4965-B794-87486BD7F92EQ36964608-ED7D963E-56E8-4EC3-9F64-FE8F557F4A47Q37090668-81731D59-DBBB-46EC-AE2E-C48D89A7ADEEQ37134227-B06C8DD1-68A8-4DE6-BB60-15A9D12DD52DQ37312768-63C78506-79E3-4A10-A277-B00A63876693Q37513642-5C0854CB-EE8C-40F4-9C07-521E9DD4C350Q37662623-367344D6-55E0-4104-BFE2-BCAEAD1DE06AQ37789695-C8BF30A8-3A43-4C82-A60E-F30E8CF99C2BQ37992245-4BE0A857-861D-49C5-8EC5-5D1AB5A56AC1Q38083493-E1CA6119-B469-49DD-9895-64B711E9A77DQ43008544-B32C7218-8586-4130-A79B-5EBF52694273Q43135240-2578D65C-F848-42C1-8AD3-507838BDE907Q44884735-135191B8-B76F-4097-9E25-89DA92397635Q46850181-BEF91F64-682E-48B0-8C4B-9AC4DAF92E04Q47095200-3CAA5C4A-9A5C-4E16-8FBC-FA027BD5FF8BQ47146370-A033E10A-C831-43BB-AE3B-BF193FA22668Q50984764-D6C69E63-7661-4346-B014-3B0104BD5118Q51227314-96E3E149-1ACF-42F0-B702-5BC927E14B99Q53228723-565FB66E-9483-4E11-8F17-BEA7D634C474
P2860
Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Complementary and alternative ...... esults from a national survey.
@en
Complementary and alternative ...... esults from a national survey.
@nl
type
label
Complementary and alternative ...... esults from a national survey.
@en
Complementary and alternative ...... esults from a national survey.
@nl
prefLabel
Complementary and alternative ...... esults from a national survey.
@en
Complementary and alternative ...... esults from a national survey.
@nl
P2093
P2860
P1476
Complementary and alternative ...... esults from a national survey.
@en
P2093
Allan Best
Gaia Pocobelli
Marja J Verhoef
Robert J Hilsden
P2860
P304
P356
10.1111/J.1572-0241.2003.07519.X
P407
P577
2003-07-01T00:00:00Z